Electromedical Technologies Valuation
| EMED Stock | USD 0.0003 0.0001 25.00% |
Electromedical Technologies seems to be fairly valued based on Macroaxis valuation methodology. Our model computes the value of Electromedical Technologies from reviewing the firm fundamentals such as Current Valuation of 3.49 M, price to sales of 1.53 X, and Shares Owned By Insiders of 11.80 % as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Electromedical Technologies' price fluctuation is out of control at this time. Calculation of the real value of Electromedical Technologies is based on 3 months time horizon. Increasing Electromedical Technologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Electromedical pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Electromedical Technologies. Since Electromedical Technologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Electromedical Pink Sheet. However, Electromedical Technologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.0E-4 | Real 2.95E-4 | Hype 3.2E-4 |
The real value of Electromedical Pink Sheet, also known as its intrinsic value, is the underlying worth of Electromedical Technologies Company, which is reflected in its stock price. It is based on Electromedical Technologies' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Electromedical Technologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Electromedical Technologies helps investors to forecast how Electromedical pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Electromedical Technologies more accurately as focusing exclusively on Electromedical Technologies' fundamentals will not take into account other important factors: Electromedical Technologies Total Value Analysis
Electromedical Technologies is currently forecasted to have valuation of 3.49 M with market capitalization of 1.64 M, debt of 673.28 K, and cash on hands of 65.23 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Electromedical Technologies fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.49 M | 1.64 M | 673.28 K | 65.23 K |
Electromedical Technologies Investor Information
The company recorded a loss per share of 0.15. Electromedical Technologies had not issued any dividends in recent years. The entity had 1:5 split on the May 9, 2001. Based on the key indicators related to Electromedical Technologies' liquidity, profitability, solvency, and operating efficiency, Electromedical Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Electromedical Technologies Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Electromedical Technologies has an asset utilization ratio of 64.71 percent. This indicates that the Company is making $0.65 for each dollar of assets. An increasing asset utilization means that Electromedical Technologies is more efficient with each dollar of assets it utilizes for everyday operations.Electromedical Technologies Ownership Allocation
Electromedical Technologies holds a total of 172.88 Million outstanding shares. Electromedical Technologies shows 11.8 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Electromedical Technologies Profitability Analysis
The company reported the previous year's revenue of 907.36 K. Net Loss for the year was (8.48 M) with profit before overhead, payroll, taxes, and interest of 708.13 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Electromedical Technologies' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Electromedical Technologies and how it compares across the competition.
About Electromedical Technologies Valuation
The pink sheet valuation mechanism determines Electromedical Technologies' current worth on a weekly basis. Our valuation model uses a comparative analysis of Electromedical Technologies. We calculate exposure to Electromedical Technologies's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Electromedical Technologies's related companies.Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. The company was founded in 2002 and is headquartered in Scottsdale, Arizona. Electromedical Technologies operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 7 people.
8 Steps to conduct Electromedical Technologies' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Electromedical Technologies' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Electromedical Technologies' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Electromedical Technologies' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Electromedical Technologies' revenue streams: Identify Electromedical Technologies' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Electromedical Technologies' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Electromedical Technologies' growth potential: Evaluate Electromedical Technologies' management, business model, and growth potential.
- Determine Electromedical Technologies' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Electromedical Technologies' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Electromedical Technologies Growth Indicators
Investing in growth stocks can be very risky. If the company such as Electromedical Technologies does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 87.7 M | |
| Retained Earnings | -21.9 M |
Complementary Tools for Electromedical Pink Sheet analysis
When running Electromedical Technologies' price analysis, check to measure Electromedical Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromedical Technologies is operating at the current time. Most of Electromedical Technologies' value examination focuses on studying past and present price action to predict the probability of Electromedical Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromedical Technologies' price. Additionally, you may evaluate how the addition of Electromedical Technologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |